Document Detail

Endurance exercise training does not alter lipolytic or adipose tissue blood flow sensitivity to epinephrine.
MedLine Citation:
PMID:  10444429     Owner:  NLM     Status:  MEDLINE    
We evaluated the relationship between lipolysis and adipose tissue blood flow (ATBF) in response to epinephrine and the effect of endurance exercise training on these responses. Five healthy untrained men underwent a four-stage incremental epinephrine infusion (0.00125, 0.005, 0.0125, and 0.025 microgram. kg fat free mass(-1). min(-1)) plus hormonal clamp before and after 16 wk of cycle ergometry exercise training. Whole body glycerol and free fatty acid (FFA) rates of appearance (R(a)) in plasma were determined by stable isotope methodology, and ATBF was assessed by (133)Xe clearance. After each training session, subjects were fed the approximate number of calories expended during exercise to prevent changes in body weight. Glycerol R(a), FFA R(a), and ATBF increased when plasma epinephrine concentration reached 0.8 nM, but at plasma epinephrine concentrations >1.6 nM ATBF plateaued, whereas lipolysis continued to increase. Exercise training increased peak oxygen uptake by 24 +/- 7% (2.9 +/- 0.2 vs. 3.6 +/- 0.1 l/min; P < 0. 05) but did not alter body weight [70.5 +/- 3.8 vs. 72.0 +/- 3.8 kg; P = nonsignificant (NS)] or percent body fat (18.4 +/- 1.6 vs. 17.8 +/- 1.9%; P = NS). Lipolytic and ATBF responses to epinephrine were also the same before and after training. We conclude that the lipolytic and ATBF responses to epinephrine are coordinated when plasma epinephrine concentration is </=1.6 nM, but that at higher epinephrine concentrations, lipolysis continues to increase while ATBF remains constant. Endurance exercise training does not change lipolytic or ATBF sensitivity to epinephrine infusion in vivo during resting conditions.
J F Horowitz; R J Braudy; W H Martin; S Klein
Related Documents :
986609 - Adipose tissue blood flow during prolonged, heavy exercise.
8541799 - Extreme derangements of acid-base balance in exercise: advantages and limitations of th...
2325699 - Excessive plasma k+ increase after ischemic exercise in myotonic muscular dystrophy.
3881209 - Lack of effect of naloxone in a moderate dosage on the exercise-induced increase in blo...
19500809 - Free fatty acid kinetics in the late phase of postexercise recovery: importance of rest...
6693309 - Tissue pressure and plasma oncotic pressure during exercise.
25427819 - Symptomatic chronic obstructive pulmonary disease in clinical trials and in a populatio...
12586519 - Amplitude and spectral characteristics of biceps brachii semg depend upon speed of isom...
23830129 - Treatment of exercise-induced bronchoconstriction.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The American journal of physiology     Volume:  277     ISSN:  0002-9513     ISO Abbreviation:  Am. J. Physiol.     Publication Date:  1999 Aug 
Date Detail:
Created Date:  1999-09-23     Completed Date:  1999-09-23     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0370511     Medline TA:  Am J Physiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  E325-31     Citation Subset:  IM    
Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adipose Tissue / blood supply*
Body Composition
Epinephrine / pharmacology*
Fatty Acids / blood
Glycerol / blood
Hormones / blood
Lipolysis / drug effects*
Physical Education and Training*
Physical Endurance*
Physical Fitness
Regional Blood Flow / drug effects
Grant Support
Reg. No./Substance:
0/Fatty Acids; 0/Hormones; 51-43-4/Epinephrine; 56-81-5/Glycerol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A unique mechanism of desensitization to lipolysis mediated by beta(3)-adrenoceptor in rats with the...
Next Document:  A new model of cancer cachexia: contribution of the ubiquitin-proteasome pathway.